Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Atrium Therapeutics has successfully closed a $50 million private placement. The funding will support the company's ongoing development efforts.
Amount Raised
$50 Million
Round Type
Post-IPO Equity
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Atrium Therapeutics has announced a robust funding event with the closing of a $50 million private placement. This capital will be directed towards advancing their therapeutic development projects. The funding reflects strong support and confidence in the company's future. Investors involved have shown commitment to Atrium's vision.
Fundz sees it the moment Atrium Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Atrium Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.